Oculis birtir uppgjör fyrir annan ársfjórðung 2024 og kynnir nýjustu áfanga í rekstri félagsins
August 27, 2024 04:00 ET
|
Oculis Holding AG
ZUG, Sviss, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Félagið birti jákvæðar niðurstöður fyrir fasa 2b RELIEF rannsóknina á OCS-02 (licaminlimab) sem rennir stoðum undir möguleika á fyrstu...
Oculis Reports Q2 Financial Results and Provides Recent Company Update
August 27, 2024 04:00 ET
|
Oculis Holding AG
ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Reported positive topline results for the Phase 2b RELIEF trial of OCS-02 (licaminlimab) paving the way for potentially the first precision...
Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update
August 27, 2024 04:00 ET
|
Oculis Holding AG
Reported positive topline results for the Phase 2b RELIEF trial of OCS-02 (licaminlimab) paving the way for potentially the first precision medicine in Dry Eye Disease (DED)Phase 2 ACUITY trial of...
Matthews International Reports Results for Fiscal 2024 Third Quarter
August 01, 2024 16:15 ET
|
Matthews International Corporation
Fiscal 2024 Third Quarter Financial Highlights: Outstanding debt reduced by $12.6 million during the quarter3rd Quarter GAAP EPS of $0.06; non-GAAP adjusted EPS of $0.56SGK Brand Solutions...
Matthews International Declares Quarterly Dividend
July 24, 2024 16:15 ET
|
Matthews International Corporation
PITTSBURGH, July 24, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (NASDAQ GSM: MATW) announced that its Board of Directors declared, at its regularly scheduled meeting today, a...
Matthews International Announces Third Quarter Fiscal 2024 Earnings Release and Conference Call
July 12, 2024 16:15 ET
|
Matthews International Corporation
PITTSBURGH, July 12, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its third quarter fiscal year 2024 earnings results after the...
Matthews International Refutes Tesla Allegations
June 17, 2024 14:07 ET
|
Matthews International Corporation
PITTSBURGH, June 17, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW). On Friday evening, June 14, 2024, Tesla filed a complaint in Federal District Court in the...
Matthews International to Participate in B. Riley Securities 24th Annual Institutional Investor Conference
May 15, 2024 16:15 ET
|
Matthews International Corporation
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (NASDAQ GSM: MATW) today announced that the company is scheduled to participate in B. Riley Securities 24th Annual...
Oculis Reports Q1 2024 Financial Results and Provides Company Updates
May 08, 2024 16:10 ET
|
Oculis Holding AG
ZUG, Switzerland, May 08, 2024 (GLOBE NEWSWIRE) -- Clinical programs progressing as planned with initiation of second OCS-01 Phase 3 DIAMOND-2 trial in Diabetic Macular Edema (DME) and completion of...
Oculis Reports Q1 2024 Financial Results and Provides Company Updates
May 08, 2024 16:10 ET
|
Oculis Holding AG
Clinical programs progressing as planned with initiation of second OCS-01 Phase 3 DIAMOND-2 trial in Diabetic Macular Edema (DME) and completion of enrollment in OCS-02 (licaminlimab) Phase 2b RELIEF...